Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab : A case report
© 2023 The Authors..
Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
IDCases - 32(2023) vom: 28., Seite e01727 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Murayama, Yoshiaki [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 11.03.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.idcr.2023.e01727 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354017241 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354017241 | ||
| 003 | DE-627 | ||
| 005 | 20231226061321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.idcr.2023.e01727 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1180.xml |
| 035 | |a (DE-627)NLM354017241 | ||
| 035 | |a (NLM)36896031 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Murayama, Yoshiaki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pneumococcal meningitis in a patient with severe COVID-19 on dexamethasone and tocilizumab |b A case report |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. | ||
| 520 | |a Although various therapeutic agents have been tried for coronavirus disease-2019 (COVID-19) and evidence has accumulated, the risk of secondary infection is increased by underlying disease and immunosuppressive drugs. We report a case of pneumococcal meningitis in a patient with severe COVID-19 who was receiving dexamethasone and tocilizumab. The patient's symptoms improved with appropriate diagnosis and antimicrobial therapy, and she fortunately returned to society without any neurological sequelae of meningitis | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Meningitis | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Secondary-infection | |
| 650 | 4 | |a Streptococcus pneumoniae | |
| 650 | 4 | |a Tocilizumab | |
| 700 | 1 | |a Ishimine, Tomohiko |e verfasserin |4 aut | |
| 700 | 1 | |a Sasano, Mikio |e verfasserin |4 aut | |
| 700 | 1 | |a Todaka, Takafumi |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumoto, Takashi |e verfasserin |4 aut | |
| 700 | 1 | |a Shimabukuro, Taiga |e verfasserin |4 aut | |
| 700 | 1 | |a Yonaha, Risa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t IDCases |d 2014 |g 32(2023) vom: 28., Seite e01727 |w (DE-627)NLM241072328 |x 2214-2509 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2023 |g day:28 |g pages:e01727 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.idcr.2023.e01727 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2023 |b 28 |h e01727 | ||